Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae

Nature Microbiology

Volumn 1, Issue 6, 2016, Pages

  Band, Victor I ^a,b   Crispell, Emily K ^a,b   Napier, Brooke A ^a,b   Herrera, Carmen M ^c   Tharp, Greg K ^d   Vavikolanu, Kranthi ^a   Pohl, Jan ^e   Read, Timothy D ^a   Bosinger, Steven E ^a,b,d   Trent, M Stephen ^c   Burd, Eileen M ^a   Weiss, David S ^a,b,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d EMORY UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; COLISTIN; PHOQ PROTEIN, BACTERIA; PROTEIN HISTIDINE KINASE;

ANIMAL; DRUG EFFECTS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOUSE; MULTIDRUG RESISTANCE; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HISTIDINE KINASE; IMMUNITY, INNATE; MICE; TREATMENT FAILURE;

EID: 84974518472     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.53     Document Type: Article

References (50)

1. United States Centers for Disease Control and Prevention Antibiotic Resistance Threats in the United States (2013); http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf
2. Review on Antimicrobial Resistance Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations (2014); http://go.nature.com/GLHVCr
3. Mezzatesta, M. L., Gona, F. & Stefani, S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 7, 887-902 (2012).
4. Davin-Regli, A. & Pagès, J. M. Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment. Front Microbiol. 6, 392 (2015).
5. Sanders, W. E. & Sanders, C. C. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10, 220-241 (1997).
6. Carlet, J. & Mainardi, J. L. Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin? Clin. Microbiol. Infect. 18, 1-3 (2012).
7. Nation, R. L. & Li, J. Colistin in the 21st century. Curr. Opin. Infect. Dis. 22, 535-543 (2009).
8. Livermore, D. M. et al. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int. J. Antimicrob. Agents. 37, 415-419 (2011).
9. Kuper, K. M., Boles, D. M., Mohr, J. F. & Wanger, A. Antimicrobial susceptibility testing: a primer for clinicians. Pharmacotherapy 29, 1326-1343 (2009).
10. Napier, B. A., Band, V., Burd, E. M. & Weiss, D. S. Colistin heteroresistance in enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob. Agents Chemother. 58, 5594-5597 (2014).
11. Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91-95 (2013).
12. Claudi, B. et al. Phenotypic variation of Salmonella in host tissues delays eradication by antimicrobial chemotherapy. Cell 158, 722-733 (2014).
13. Kaiser, P. et al. Cecum lymph node dendritic cells harbor slow-growing bacteria phenotypically tolerant to antibiotic treatment. PLoS Biol. 12, e1001793 (2014).
14. Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 (2007).
15. Van Rooijen, N. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 124, 1-6 (1989).
16. Nathan, C. F. Mechanisms of macrophage antimicrobial activity. Trans. R. Soc. Trop. Med. Hyg. 77, 620-630 (1983).
17. Iles, K. E. & Forman, H. J. Macrophage signaling and respiratory burst. Immunol. Res. 26, 95-105 (2002).
18. 2+ stimulon of Escherichia coli. J. Bacteriol. 185, 3696-3702 (2003).
19. Alpuche Aranda, C. M., Swanson, J. A., Loomis, W. P. & Miller, S. I. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc. Natl Acad. Sci. USA 89, 10079-10083 (1992).
20. Zwir, I. et al. Dissecting the PhoP regulatory network of Escherichia coli and Salmonella enterica. Proc. Natl Acad. Sci. USA 102, 2862-2867 (2005).
21. Merighi, M., Ellermeier, C. D., Slauch, J. M. & Gunn, J. S. Resolvase-in vivo expression technology analysis of the Salmonella enterica serovar Typhimurium PhoP and PmrA regulons in BALB/c mice. J. Bacteriol. 187, 7407-7416 (2005).
22. Lin, Q. Y. et al. Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance. Antimicrob. Agents Chemother. 58, 5181-5190 (2014).
23. Monsieurs, P. et al. Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimurium. J. Mol. Evol. 60, 462-474 (2005).
24. Oshima, T. et al. Transcriptome analysis of all two-component regulatory system mutants of Escherichia coli K-12. Mol. Microbiol. 46, 281-291 (2002).
25. Choi, E., Groisman, E. A. & Shin, D. Activated by different signals, the PhoP/PhoQ two-component system differentially regulates metal uptake. J. Bacteriol. 191, 7174-7181 (2009).
26. Band, V. I. & Weiss, D. S. Mechanisms of antimicrobial peptide resistance in Gram-negative bacteria. Antibiotics (Basel) 4, 18-41 (2015).
27. Raetz, C. R., Reynolds, C. M., Trent, M. S. & Bishop, R. E. Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76, 295-329 (2007).
28. Keren, I., Minami, S., Rubin, E. & Lewis, K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio 2, e00100-e00111 (2011).
29. Helaine, S. et al. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343, 204-208 (2014).
30. Alexander, H. E. & Leidy, G. Mode of action of streptomycin on type B Hemophilus influenzae: II. Nature of resistant variants. J. Exp. Med. 85, 607-621 (1947).
31. Rinder, H. Hetero-resistance: an under-recognised confounder in diagnosis and therapy? J. Med. Microbiol. 50, 1018-1020 (2001).
32. Zheng, C. et al. Mixed infections and rifampin heteroresistance among mycobacterium tuberculosis clinical isolates. J. Clin. Microbiol. 53, 2138-2147 (2015).
33. El-Halfawy, O. M. & Valvano, M. A. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin. Microbiol. Rev. 28, 191-207 (2015).
34. Kao, C. Y. et al. Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment. Infect. Genet. Evol. 23, 196-202 (2014).
35. Kalivoda, E. J. et al. New vector tools with a hygromycin resistance marker for use with opportunistic pathogens. Mol. Biotechnol. 48, 7-14 (2011).
36. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K. & Pease, L. R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77, 61-68 (1989).
37. Schweizer, H. P. & Hoang, T. T. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene 158, 15-22 (1995).
38. Bryksin, A. V. & Matsumura, I. Rational design of a plasmid origin that replicates efficiently in both gram-positive and gram-negative bacteria. PLoS ONE 5, e13244 (2010).
39. Applied Biosystems. TRI Reagent Solution RNA/DNA/Protein Isolation Reagent Manual (Ambion, 2010).
40. Koren, S. et al. Hybrid error correction and de novo assembly of single-molecule sequencing reads. Nature Biotechnol. 30, 693-700 (2012).
41. Clark, S. C., Egan, R., Frazier, P. I. & Wang, Z. ALE: a generic assembly likelihood evaluation framework for assessing the accuracy of genome and metagenome assemblies. Bioinformatics 29, 435-443 (2013).
42. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
43. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
44. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memoryefficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
45. Roberts, A., Pimentel, H., Trapnell, C. & Pachter, L. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27, 2325-2329 (2011).
46. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature Protoc. 7, 562-578 (2012).
47. Götz, S. et al. High-throughput functional annotation and data mining with the Blast2GO suite. Nucleic Acids Res. 36, 3420-3435 (2008).
48. Landman, D., Salamera, J. & Quale, J. Irreproducible and uninterpretable polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol. 51, 4106-4111 (2013).
49. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nature Protoc. 3, 1101-1108 (2008).
50. Herrera, C. M., Hankins, J. V. & Trent, M. S. Activation of PmrA inhibits LpxTdependent phosphorylation of lipid A promoting resistance to antimicrobial peptides. Mol. Microbiol. 76, 1444-1460 (2010).